Display options
Share it on

Open Access Maced J Med Sci. 2019 Aug 11;7(15):2551-2555. doi: 10.3889/oamjms.2019.622. eCollection 2019 Aug 15.

The Point Prevalence Survey Research of Antibacterial Drugs' Prescription for Outpatient Treatment of Urinary System Infections.

Open access Macedonian journal of medical sciences

Gulmira Muldaeva, Aizhan Beisenayeva, Leila Arystan, Aliya Baymanova, Leila Haydargaliyeva, Anel Beisenayeva

Affiliations

  1. Department of General Medical Practice No. 2, Non-Profit Joint-Stock Company "Karaganda Medical University", Karaganda, Kazakhstan.
  2. Department of Oncology and Radiology, Non-Profit Joint-Stock Company "Karaganda Medical University", Karaganda, Kazakhstan.

PMID: 31666863 PMCID: PMC6814458 DOI: 10.3889/oamjms.2019.622

Abstract

BACKGROUND: Antibiotic resistance of microorganisms is the subject of numerous discussions and initiatives, it has a well-defined tendency to increase which is largely related to a big number of errors when prescribing antibacterial drugs at the outpatient stage of treatment and disease prevention, as well as a lack of information and data on the quantity and quality of antimicrobial therapy. One of the elements aimed at reducing antibiotic resistance growth is audit and analysis of application practice.

AIM: To assess qualitative and quantitative characteristics for urinary tract infections treatment using antimicrobial drugs by general physicians at the outpatient level.

MATERIALS AND METHODS: The Point Prevalence Survey (PPS) analysis of antimicrobial drugs prescription was conducted by general physicians of No. 1, 4, 5 Hospitals of Karaganda city. There was carried out a daily prospectively data collecting on antibacterial drugs prescription by Doctor of Medical institutions, which was performed during patients' visit. For each person who was prescribed the AD, there was filled a special questionnaire developed by the European Center for Disease Prevention and Control, including passport data, data on disease and prescription of antibacterial drugs. There were considered 200 cases of antibiotic prescription. The study included patients of both sexes, all age groups, who were prescribed the antibiotic therapy for the UTI treatment.

RESULTS: When selecting antimicrobial therapy, the Protocols for diagnosis and treatment indicate the need for a microbiological study to determine sensitivity to antibacterial drugs, that was not performed in 100% of cases, and initial treatment was empirically prescribed, namely, in 34% of cases there were used drugs from the cephalosporin group (Ceftriaxone), nitrofurans (Furazidin)-42%, fluoroquinolones (Levofloxacin)-24%. In treating acute cystitis, in most cases, alternative medications were prescribed, though according to current recommendations, first-line therapy includes fosfomycin trometamol, pivmecillins and nitrofurantoin macrocrystals, which according to the results of this study were not used at all.

CONCLUSION: In most cases (71%), alternative antibacterial drugs were prescribed for initial treatment of urinary tract infections. In majority cases, the dosage regimen of antibacterial drugs, dosage frequency, treatment course did not meet current recommendations.

Copyright: © 2019 Gulmira Muldaeva, Aizhan Beisenayeva, Leila Arystan, Aliya Baymanova, Leila Haydargaliyeva, Anel Beisenayeva.

Keywords: Antibiotic resistance; Choice of antibiotic drugs; PPS-research; Prescription; Treatment; Urinary tract infections

References

  1. J Antimicrob Chemother. 2016 Apr;71(4):1106-17 - PubMed
  2. J Urol. 2010 Jul;184(1):179-85 - PubMed
  3. Drugs. 2011 Apr 16;71(6):745-55 - PubMed
  4. Antimicrob Resist Infect Control. 2013 Jan 15;2(1):3 - PubMed
  5. Antimicrob Agents Chemother. 2015 Feb;59(2):782-9 - PubMed
  6. Clin Infect Dis. 2009 Nov 15;49(10):1496-504 - PubMed
  7. J Antimicrob Chemother. 2011 Mar;66(3):650-6 - PubMed
  8. J Antimicrob Chemother. 2006 Jun;57(6):1189-96 - PubMed
  9. J Chemother. 2013 Aug;25(4):222-8 - PubMed
  10. BMJ Open. 2016 Nov 3;6(11):e012675 - PubMed
  11. J Antimicrob Chemother. 2011 Feb;66(2):443-9 - PubMed
  12. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD003543 - PubMed
  13. Clin Infect Dis. 2011 Mar 1;52(5):e103-20 - PubMed
  14. PLoS One. 2016 May 16;11(5):e0154662 - PubMed
  15. Antibiotics (Basel). 2014 Sep 10;3(3):450-60 - PubMed
  16. J Antimicrob Chemother. 2012 Apr;67(4):1020-6 - PubMed
  17. Drugs. 2010 Feb 12;70(3):313-33 - PubMed
  18. Antimicrob Resist Infect Control. 2012 Feb 14;1(1):11 - PubMed
  19. J Infect Public Health. 2015 Jan-Feb;8(1):55-61 - PubMed
  20. Pediatr Infect Dis J. 2013 Jun;32(6):e242-53 - PubMed
  21. Euro Surveill. 2012 Nov 15;17(46):null - PubMed

Publication Types